The latest arrival of this new formulation represents a possibly significant advancement in the handling of type 2 the condition . This drug builds upon the prior success of lower dosages , showing impressive results in improving blood glucose readings and aiding weight loss . Clinicians are exploring its full benefit on heart outcomes and related